Key impacts and achievements from 2017/2018
- We recruited 738 participants to NIHR portfolio studies (exceeding our target of 702)
- We had 91 articles accepted in high quality journals, books and book reviews
- We are the top recruiting organisation to Dementia studies in the West Midlands
- We participated in the first human trial of disease modification in Huntington disease (IONIS-HD)
- 105 research teams have been supported by the R&I governance team at various stages of the research pathway
- 38 requests for service evaluation support were received compared to 20 in 16/17 and 23 Service Evaluation approvals were issued (more than double that of the previous year). The majority of individuals had not approached the research and innovation department previously.
- 14 teams/individuals have contacted us in relation to innovation ideas.
- We were awarded ‘Innovative Organisation of the Year’ and our CADDI (Capacity and Demand Dashboard Information) awarded ‘Mental Health Innovation’ at the WM AHSN’s Celebration of Innovation awards
- 100% of patients recruited to NIHR portfolio studies were achieved within the first 30 days post approval
